相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Peak neutralizing and cross-neutralizing antibody levels to human papillomavirus types 6/16/18/31/33/45/52/58 induced by bivalent and quadrivalent HPV vaccines
Filipe Colaco Mariz et al.
NPJ VACCINES (2020)
Outer Membrane Lipid Secretion and the Innate Immune Response to Gram-Negative Bacteria
Nicole P. Giordano et al.
INFECTION AND IMMUNITY (2020)
Suppression of Inflammasome Activation by IRF8 and IRF4 in cDCs Is Critical for T Cell Priming
Margaret M. McDaniel et al.
CELL REPORTS (2020)
HPV16 L1 diversity and its potential impact on the vaccination-induced immunity
Aissam El Aliani et al.
GENE (2020)
Long-term HPV-specific immune response after one versus two and three doses of bivalent HPV vaccination in Dutch girls
Hella Pasmans et al.
VACCINE (2019)
A lipid A-based TLR4 mimetic effectively adjuvants a Yersinia pestis rF-V1 subunit vaccine in a murine challenge model
Kelsey A. Gregg et al.
VACCINE (2018)
Human papillomavirus vaccination update Nonavalent vaccine and the two-dose schedule
Julia M. L. Brotherton
AUSTRALIAN JOURNAL OF GENERAL PRACTICE (2018)
Two-dose schedules for human papillomavirus vaccine: Systematic review and meta-analysis
Maddalena D'Addario et al.
VACCINE (2017)
Rationally Designed TLR4 Ligands for Vaccine Adjuvant Discovery
Kelsey A. Gregg et al.
MBIO (2017)
Progress and prospects for L2-based human papillomavirus vaccines
Rosie T. Jiang et al.
EXPERT REVIEW OF VACCINES (2016)
Circulating CXCR5+CD4+ T Follicular-Like Helper Cell and Memory B Cell Responses to Human Papillomavirus Vaccines
Ken Matsui et al.
PLOS ONE (2015)
Inducing Dose Sparing with Inactivated Polio Virus Formulated in Adjuvant CAF01
Jes Dietrich et al.
PLOS ONE (2014)
Preparation and properties of a papillomavirus infectious intermediate and its utility for neutralization studies
Joshua W. Wang et al.
VIROLOGY (2014)
A comparative review of toll-like receptor 4 expression and functionality in different animal species
Celine Vaure et al.
FRONTIERS IN IMMUNOLOGY (2014)
Efficacy of RG1-VLP Vaccination against Infections with Genital and Cutaneous Human Papillomaviruses
Christina Schellenbacher et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Phylogenetic Considerations in Designing a Broadly Protective Multimeric L2 Vaccine
Subhashini Jagu et al.
JOURNAL OF VIROLOGY (2013)
Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease
Beatriz Serrano et al.
INFECTIOUS AGENTS AND CANCER (2012)
Follicular Helper CD4 T Cells (T-FH)
Shane Crotty
ANNUAL REVIEW OF IMMUNOLOGY, VOL 29 (2011)
Development and Characterization of Synthetic Glucopyranosyl Lipid Adjuvant System as a Vaccine Adjuvant
Rhea N. Coler et al.
PLOS ONE (2011)
A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine for use in the prevention of visceral leishmaniasis
Jaya Chakravarty et al.
VACCINE (2011)
The N-terminal region of the human papillomavirus L2 protein contains overlapping binding sites for neutralizing, cross-neutralizing and non-neutralizing antibodies
Ivonne Rubio et al.
VIROLOGY (2011)
Kinetics of Immune Responses to Influenza Virus-Like Particles and Dose-Dependence of Protection with a Single Vaccination
Fu Shi Quan et al.
JOURNAL OF VIROLOGY (2009)
Chimeric L1-L2 Virus-Like Particles as Potential Broad-Spectrum Human Papillomavirus Vaccines
Christina Schellenbacher et al.
JOURNAL OF VIROLOGY (2009)
A protective and broadly cross-neutralizing epitope of human papillomavirus L2
Ratish Gambhira et al.
JOURNAL OF VIROLOGY (2007)
Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16
XJS Chen et al.
MOLECULAR CELL (2000)
分享论文
